Baylor Genetics Chief Medical Officer Christine Eng, M.D., Shares Sequencing Approaches for Undiagnosed Patients at Precision Medicine World Conference 2024
January 23, 2024 09:00 ET
|
Baylor Genetics
Showcase Presentation to Include Case Examples from NIH’s Undiagnosed Diseases Network (UDN)
Newborn Metabolic Screening Market Size is Projected to Grow from US$ 295.7 Million in 2022 to US$ 757.9 Million by 2032, Exhibiting a CAGR of 8.9% | Persistence Market Research
January 22, 2024 03:15 ET
|
Persistence Market Research
New York, Jan. 22, 2024 (GLOBE NEWSWIRE) -- Newborn Metabolic Screening Market Overview: The Newborn Metabolic Screening Market is a crucial component of newborn healthcare, aimed at detecting...
Baylor Genetics Accelerates Growth, Combines Clinical and Scientific Expertise with Commercial Capabilities to Meet Increased Needs of Patients, Providers and Partners
January 03, 2024 10:00 ET
|
Baylor Genetics
Company Expands Test Offerings, Lab Technology, and Customer-Centric Tools Rapid Comprehensive Whole Genome and Exome Sequencing, Disease-Specific Panels and Customizable Solutions Advance Diagnoses...
Understanding Resilience to Schizophrenia through Genetics - A Free Webinar from the Brain & Behavior Research Foundation
December 05, 2023 10:45 ET
|
Brain & Behavior Research Foundation
New York, Dec. 05, 2023 (GLOBE NEWSWIRE) -- The Brain & Behavior Research Foundation (BBRF) is hosting a free webinar, “Understanding Resilience to Schizophrenia through Genetics” on Tuesday,...
RNA Based Therapeutics Market Is Projected to Gain $25,121.95 Million by 2030: Allied Market Research
November 15, 2023 10:42 ET
|
Allied Market Research
Wilmington, Delaware, Nov. 15, 2023 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, “RNA Based Therapeutics Market by Disease Type (RNA antisense and RNA interference (RNAi)),...
Baylor Genetics to Present Scientific Research Findings at Upcoming NORD, NSGC and ASHG Conferences
October 02, 2023 10:00 ET
|
Baylor Genetics
Baylor Genetics to present at three top genetic conferences on WES, WGS, carrier screening and non-invasive prenatal testing
Baylor Genetics Announces Neurodevelopmental Disorders Test Panel to Help Healthcare Providers Diagnose Patients with Intellectual Disabilities or Developmental Delays
September 12, 2023 08:00 ET
|
Baylor Genetics
HOUSTON, Sept. 12, 2023 (GLOBE NEWSWIRE) -- Baylor Genetics, a clinical diagnostic laboratory at the forefront of genetic testing, today announced the availability of a new Neurodevelopmental...
Carrier Screening Market to accrue USD 6 billion by 2032, Says Graphical Research Powered by GMI
June 11, 2023 21:00 ET
|
Graphical Research
Selbyville, Delaware, June 11, 2023 (GLOBE NEWSWIRE) -- Carrier Screening Market size is slated to reach USD 6 billion by 2032. Growing demand for personalized medicine will act as a major factor...
Viral Vector Production Market to Reach USD 17.3 Bn by 2031, growing at a CAGR of 4.4%: as per TMR Study
May 09, 2023 08:30 ET
|
Transparency Market Research
Wilmington, Delaware, United States, May 09, 2023 (GLOBE NEWSWIRE) -- The global viral vector production market stood at USD 16.7 Bn in 2022 and is anticipated to exceed USD 17.3 Bn by 2031,...
Enzymatic DNA Synthesis Market Worth $2.24 Billion, by 2028 with 45.1% CAGR – Global Report by The Insight Partners
February 28, 2023 08:28 ET
|
The Insight Partners
New York, Feb. 28, 2023 (GLOBE NEWSWIRE) -- According to The Insight Partners, “Enzymatic DNA Synthesis Market Size, Share, Trends, Growth and Global Forecast to 2028 - COVID-19 Impact and Global...